Michael C. Keefer

5.4k total citations
71 papers, 2.2k citations indexed

About

Michael C. Keefer is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, Michael C. Keefer has authored 71 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Virology, 33 papers in Immunology and 21 papers in Infectious Diseases. Recurrent topics in Michael C. Keefer's work include HIV Research and Treatment (46 papers), Immune Cell Function and Interaction (21 papers) and vaccines and immunoinformatics approaches (15 papers). Michael C. Keefer is often cited by papers focused on HIV Research and Treatment (46 papers), Immune Cell Function and Interaction (21 papers) and vaccines and immunoinformatics approaches (15 papers). Michael C. Keefer collaborates with scholars based in United States, South Africa and France. Michael C. Keefer's co-authors include David C. Montefiori, Kent J. Weinhold, Barney S. Graham, Lawrence Corey, M. Juliana McElrath, Geoffrey J. Gorse, Mark J. Mulligan, Thomas G. Evans, Patricia Fast and Robert B. Belshe and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Michael C. Keefer

70 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael C. Keefer United States	31	1.3k	918	730	691	647	71	2.2k
Patricia Fast United States	29	843 0.7×	716 0.8×	1.2k 1.6×	1.1k 1.6×	670 1.0×	77	2.6k
Cheryl Cameron United States	24	615 0.5×	740 0.8×	870 1.2×	665 1.0×	427 0.7×	46	2.2k
Nilu Goonetilleke United States	24	1.5k 1.2×	1.6k 1.7×	910 1.2×	1.4k 2.0×	650 1.0×	72	3.0k
T. Blake Ball Canada	33	1.6k 1.3×	1.3k 1.4×	793 1.1×	949 1.4×	600 0.9×	107	3.2k
Vladimir Novitsky United States	29	2.4k 1.9×	721 0.8×	685 0.9×	1.9k 2.8×	676 1.0×	95	3.1k
Sorachai Nitayaphan Thailand	26	1.0k 0.8×	503 0.5×	437 0.6×	951 1.4×	291 0.4×	82	1.8k
Saladin Osmanov Switzerland	27	2.7k 2.2×	482 0.5×	769 1.1×	2.2k 3.2×	538 0.8×	56	3.2k
Vladimír Liška United States	14	1.4k 1.1×	702 0.8×	586 0.8×	570 0.8×	278 0.4×	36	1.6k
Mary E. Enama United States	21	502 0.4×	702 0.8×	811 1.1×	1.2k 1.7×	493 0.8×	30	2.3k
Leigh Anne Eller United States	20	1.2k 1.0×	561 0.6×	639 0.9×	726 1.1×	472 0.7×	62	1.8k

Countries citing papers authored by Michael C. Keefer

Since Specialization

Citations

This map shows the geographic impact of Michael C. Keefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Keefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Keefer more than expected).

Fields of papers citing papers by Michael C. Keefer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Keefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Keefer. The network helps show where Michael C. Keefer may publish in the future.

Co-authorship network of co-authors of Michael C. Keefer

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Keefer. A scholar is included among the top collaborators of Michael C. Keefer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Keefer. Michael C. Keefer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lin, Li‐Yun, Mkunde Chachage, Géraldine Laumond, et al.. (2025). Deciphering HIV vaccine-induced antibody response according to ethnicity. AIDS. 39(8). 957–963.

Henrich, Timothy J., Ronald J. Bosch, Catherine Godfrey, et al.. (2024). Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIV. Cell Reports Medicine. 5(10). 101745–101745. 5 indexed citations

Mosmann, Tim R., Jonathan A. Rebhahn, Stephen C. De Rosa, et al.. (2024). SWIFT clustering analysis of intracellular cytokine staining flow cytometry data of the HVTN 105 vaccine trial reveals high frequencies of HIV-specific CD4+ T cell responses and associations with humoral responses. Frontiers in Immunology. 15. 1347926–1347926. 1 indexed citations

Fucile, Christopher, Michael S. Piepenbrink, Catherine A. Bunce, et al.. (2023). Mixed Origins: HIV gp120-Specific Memory Develops from Pre-Existing Memory and Naive B Cells Following Vaccination in Humans. AIDS Research and Human Retroviruses. 39(7). 350–366. 2 indexed citations

Curlin, Marcel E., Jason Shao, Gabriela Diaz, et al.. (2020). Long-term mucosal T cell activation and homing phenotypes in recipients of an Ad5-vectored HIV vaccine. Vaccine. 38(36). 5814–5821. 2 indexed citations

Alio, Amina P., et al.. (2020). House Ball Community Leaders’ Perceptions of HIV and HIV Vaccine Research. SHILAP Revista de lepidopterología. 9(1). 136–145. 4 indexed citations

Stephenson, Kathryn E., Michael C. Keefer, Catherine A. Bunce, et al.. (2018). First-in-human randomized controlled trial of an oral, replicating adenovirus 26 vector vaccine for HIV-1. PLoS ONE. 13(11). e0205139–e0205139. 28 indexed citations

Nogales, Aitor, Michael S. Piepenbrink, Jiong Wang, et al.. (2018). A Highly Potent and Broadly Neutralizing H1 Influenza-Specific Human Monoclonal Antibody. Scientific Reports. 8(1). 4374–4374. 53 indexed citations

Kobie, James J., Bo Zheng, Michael S. Piepenbrink, et al.. (2015). Functional and Molecular Characteristics of Novel and Conserved Cross-Clade HIV Envelope Specific Human Monoclonal Antibodies. Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 34(2). 65–72. 6 indexed citations

10.

Kopycinski, Jakub, Peter Hayes, Hannah M. Cheeseman, et al.. (2014). Broad HIV Epitope Specificity and Viral Inhibition Induced by Multigenic HIV-1 Adenovirus Subtype 35 Vector Vaccine in Healthy Uninfected Adults. PLoS ONE. 9(3). e90378–e90378. 11 indexed citations

11.

Walsh, Stephen R., Michael S. Seaman, Lauren E. Grandpre, et al.. (2012). Impact of anti-orthopoxvirus neutralizing antibodies induced by a heterologous prime-boost HIV-1 vaccine on insert-specific immune responses. Vaccine. 31(1). 114–119. 8 indexed citations

12.

Keefer, Michael C., Sharon E. Frey, Marnie Elizaga, et al.. (2011). A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects☆☆☆. Vaccine. 29(10). 1948–1958. 38 indexed citations

13.

Love, Tanzy, Sally W. Thurston, Michael C. Keefer, Stephen Dewhurst, & Ha Youn Lee. (2010). Mathematical Modeling of Ultradeep Sequencing Data Reveals that Acute CD8 ⁺ T-Lymphocyte Responses Exert Strong Selective Pressure in Simian Immunodeficiency Virus-Infected Macaques but Still Fail To Clear Founder Epitope Sequences. Journal of Virology. 84(11). 5802–5814. 18 indexed citations

14.

Russell, Nina D., Barney S. Graham, Michael C. Keefer, et al.. (2006). Phase 2 Study of an HIV-1 Canarypox Vaccine (vCP1452) Alone and in Combination With rgp120. JAIDS Journal of Acquired Immune Deficiency Syndromes. 44(2). 203–212. 69 indexed citations

15.

Wright, Peter F., Jiří Městecký, M. Juliana McElrath, et al.. (2004). Comparison of Systemic and Mucosal Delivery of 2 Canarypox Virus Vaccines Expressing either HIV‐1 Genes or the Gene for Rabies Virus G Protein. The Journal of Infectious Diseases. 189(7). 1221–1231. 45 indexed citations

16.

Bruyn, Guy de, Anthony Rossini, Ya-Lin Chiu, et al.. (2003). Safety profile of recombinant canarypox HIV vaccines. Vaccine. 22(5-6). 704–713. 53 indexed citations

17.

Evans, Thomas G., M. Juliana McElrath, Thomas J. Matthews, et al.. (2001). QS-21 promotes an adjuvant effect allowing for reduced antigen dose during HIV-1 envelope subunit immmunization in humans. Vaccine. 19(15-16). 2080–2091. 106 indexed citations

18.

McElrath, M. Juliana, Lawrence Corey, David C. Montefiori, et al.. (2000). A Phase II Study of Two HIV Type 1 Envelope Vaccines, Comparing Their Immunogenicity in Populations at Risk for Acquiring HIV Type 1 Infection. AIDS Research and Human Retroviruses. 16(9). 907–919. 45 indexed citations

19.

Evans, Thomas G., Michael C. Keefer, Kent J. Weinhold, et al.. (1999). A Canarypox Vaccine Expressing Multiple Human Immunodeficiency Virus Type 1 Genes Given Alone or with Rgp120 Elicits Broad and Durable CD8⁺Cytotoxic T Lymphocyte Responses in Seronegative Volunteers. The Journal of Infectious Diseases. 180(2). 290–298. 134 indexed citations

20.

Keefer, Michael C., Barney S. Graham, Robert B. Belshe, et al.. (1994). Studies of High Doses of a Human Immunodeficiency Virus Type 1 Recombinant Glycoprotein 160 Candidate Vaccine in HIV Type 1-Seronegative Humans. AIDS Research and Human Retroviruses. 10(12). 1713–1723. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact